Shanghai Pharmaceuticals Holding Co.,Ltd.’s Net Profit Rose 9.6% in First Half of 2022

Shanghai Pharmaceuticals Holding Co.,Ltd. (上海医药集团股份有限公司) (601607.SH) reported a net profit of 4.6 billion yuan in the first half of 2022, up 9.6% year-on-year.

Meanwhile, the company posted 111.7 billion yuan in revenue, up 6.1% year-on-year.

At the end of the reporting period, it had 187.2 billion yuan in total assets and 111.4 billion yuan in total liabilities, with a liability-to-asset ratio of 59.5%.